Ctt Pharmaceutical Holdings Stock Volatility
| CTTH Stock | USD 0.06 0.01 8.95% |
CTT Pharmaceutical is out of control given 3 months investment horizon. CTT Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.0684, which signifies that the company had a 0.0684% return per unit of volatility over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.69% are justified by taking the suggested risk. Use CTT Pharmaceutical mean deviation of 7.94, and Risk Adjusted Performance of 0.0575 to evaluate company specific risk that cannot be diversified away. Key indicators related to CTT Pharmaceutical's volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
CTT Pharmaceutical Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of CTT daily returns, and it is calculated using variance and standard deviation. We also use CTT's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of CTT Pharmaceutical volatility.
CTT |
Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of CTT Pharmaceutical at lower prices. For example, an investor can purchase CTT stock that has halved in price over a short period. This will lower their average cost per share, thereby improving the overall portfolio performance when market normalizes.
CTT Pharmaceutical Market Sensitivity And Downside Risk
CTT Pharmaceutical's beta coefficient measures the volatility of CTT pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents CTT pink sheet's returns against your selected market. In other words, CTT Pharmaceutical's beta of -0.89 provides an investor with an approximation of how much risk CTT Pharmaceutical pink sheet can potentially add to one of your existing portfolios. CTT Pharmaceutical Holdings is showing large volatility of returns over the selected time horizon. CTT Pharmaceutical Holdings is a penny stock. Although CTT Pharmaceutical may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in CTT Pharmaceutical Holdings. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on CTT instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze CTT Pharmaceutical Demand TrendCheck current 90 days CTT Pharmaceutical correlation with market (Dow Jones Industrial)CTT Beta |
CTT standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 24.72 |
It is essential to understand the difference between upside risk (as represented by CTT Pharmaceutical's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of CTT Pharmaceutical's daily returns or price. Since the actual investment returns on holding a position in ctt pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in CTT Pharmaceutical.
CTT Pharmaceutical Pink Sheet Volatility Analysis
Volatility refers to the frequency at which CTT Pharmaceutical pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with CTT Pharmaceutical's price changes. Investors will then calculate the volatility of CTT Pharmaceutical's pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of CTT Pharmaceutical's volatility:
Historical Volatility
This type of pink sheet volatility measures CTT Pharmaceutical's fluctuations based on previous trends. It's commonly used to predict CTT Pharmaceutical's future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for CTT Pharmaceutical's current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on CTT Pharmaceutical's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. CTT Pharmaceutical Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
CTT Pharmaceutical Projected Return Density Against Market
Given the investment horizon of 90 days CTT Pharmaceutical Holdings has a beta of -0.8866 suggestingMost traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CTT Pharmaceutical or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CTT Pharmaceutical's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CTT pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
CTT Pharmaceutical Holdings has an alpha of 1.6112, implying that it can generate a 1.61 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a CTT Pharmaceutical Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.CTT Pharmaceutical Pink Sheet Risk Measures
Given the investment horizon of 90 days the coefficient of variation of CTT Pharmaceutical is 1462.46. The daily returns are distributed with a variance of 611.02 and standard deviation of 24.72. The mean deviation of CTT Pharmaceutical Holdings is currently at 8.02. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | 1.61 | |
β | Beta against Dow Jones | -0.89 | |
σ | Overall volatility | 24.72 | |
Ir | Information ratio | 0.06 |
CTT Pharmaceutical Pink Sheet Return Volatility
CTT Pharmaceutical historical daily return volatility represents how much of CTT Pharmaceutical pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 24.7187% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7777% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About CTT Pharmaceutical Volatility
Volatility is a rate at which the price of CTT Pharmaceutical or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of CTT Pharmaceutical may increase or decrease. In other words, similar to CTT's beta indicator, it measures the risk of CTT Pharmaceutical and helps estimate the fluctuations that may happen in a short period of time. So if prices of CTT Pharmaceutical fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.
CTT Pharmaceutical's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on CTT Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much CTT Pharmaceutical's price varies over time.
3 ways to utilize CTT Pharmaceutical's volatility to invest better
Higher CTT Pharmaceutical's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of CTT Pharmaceutical stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. CTT Pharmaceutical stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of CTT Pharmaceutical investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in CTT Pharmaceutical's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of CTT Pharmaceutical's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
CTT Pharmaceutical Investment Opportunity
CTT Pharmaceutical Holdings has a volatility of 24.72 and is 31.69 times more volatile than Dow Jones Industrial. 96 percent of all equities and portfolios are less risky than CTT Pharmaceutical. You can use CTT Pharmaceutical Holdings to protect your portfolios against small market fluctuations. The pink sheet experiences a very speculative downward sentiment. The market maybe over-reacting. Check odds of CTT Pharmaceutical to be traded at $0.0551 in 90 days.Good diversification
The correlation between CTT Pharmaceutical Holdings and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CTT Pharmaceutical Holdings and DJI in the same portfolio, assuming nothing else is changed.
CTT Pharmaceutical Additional Risk Indicators
The analysis of CTT Pharmaceutical's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in CTT Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some common measures of CTT Pharmaceutical pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0575 | |||
| Market Risk Adjusted Performance | (1.69) | |||
| Mean Deviation | 7.94 | |||
| Semi Deviation | 9.81 | |||
| Downside Deviation | 15.48 | |||
| Coefficient Of Variation | 1598.35 | |||
| Standard Deviation | 24.21 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
CTT Pharmaceutical Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against CTT Pharmaceutical as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. CTT Pharmaceutical's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, CTT Pharmaceutical's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to CTT Pharmaceutical Holdings.
Complementary Tools for CTT Pink Sheet analysis
When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |